Castle Biosciences

Castle Biosciences

CSTL· Services· Fiscal year ends in December

CEO pay in FY2025Stock +46.0% in FY2025

Derek J. Maetzold is the CEO of Castle Biosciences and was paid $6.8M in FY2025 (Dec), down 2%.

Pay$100 in the stock at the end of FY20 → $58
CEO pay is from each Castle Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Derek J. MaetzoldFY2025
  2. 2Frank StokesFY2025
  3. 3Kristen M. OelschlagerFY2025
  4. 4Tobin W. JuvenalFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Castle Biosciences paid its 4 named executives $13.9M in total in FY2025 (Dec). CEO Derek J. Maetzold was paid $6.8M of that.

Name
Derek J. MaetzoldPresident and CEO
Frank StokesChief Financial Officer
Kristen M. OelschlagerChief Operating Officer
Tobin W. JuvenalChief Commercial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2024 (Dec) proxy of Castle Biosciences names 17 peer companies for pay. Among Castle Biosciences and these peers, CEO pay was 7th highest of 9 and total shareholder return was 5th highest of 9.

7th highest of 9in Castle Biosciences and its pay peers, FY2024 (Dec) by CEO pay:

$5.0M$13.0M

5th highest of 9in Castle Biosciences and its pay peers, FY2024 (Dec) by total shareholder return:

$20$470

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Ellen GoldbergDirector · 4 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A

Filings6

See all
Proxy statementDEF 14AApr 8, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 9, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 10, 2024FY2023
Annual report10-KFeb 28, 2024FY2023